Though ELISA tests (enzyme-linked immunosorbent assays) are the gold standard for diagnosing a whole slew of infectious diseases, the technology has remained stuck within hospital labs. What if you ...

The ELISA test is much more elaborate and time-consuming and the results are authentic, said microbiologists. "It is more profitable for laboratories to conduct rapid tests because that way they can ...

The launch follows increasing demand from the scientific community to study penKid - a biomarker reflecting the current state of kidney function in critical care environments. While SphingoTec's ...

COVID-19 has thrown ELISA testing into the spotlight and driven advances in technology allowing the process to become quicker and more accurate. While there are limits to ELISA antibody tests’ ...

Scientists say they have developed a new computational method to reduce variability in common research biomarker tests. They see their techniques as a promising step in improving the ability of ...

Immunoglobulin (Ig)G and IgE appeared in only 10% of samples tested for possible allergic bronchopulmonary aspergillosis, based on data from more than 500 individuals presented at the American Academy ...

NEW YORK, Oct. 3, 2024 /PRNewswire/ -- Report on how AI is driving market transformation- The global enzyme-linked immunosorbent assay (elisa) market size is estimated to grow by USD 843.9 million ...